September 1, 2021
(“IQ-AI” or the “Company”)
IQ-AI shares to commence trading on the OTCQB Venture Market in the United States
IQ-AI Limited (LSE: IQAI) is pleased to announce that the Company’s ordinary shares will today begin trading on the OTCQB Venture Market (“OTCQB”) in the United States, under the ticker symbol “IQAIF”.
The Company’s objective in listing its shares on the OTCQB is to provide more efficient access to a new and materially larger pool of prospective US investors. The Directors believe that IQ-AI’s OTCQB listing will enable the Company to engage with a significant network of US investors, data distributors and media partners, ensuring that US investors have access to the same level of information and disclosure that is available to investors in the United Kingdom.
The OTCQB trading facility is provided through OTC Markets Group Inc, located in New York. OTC Markets Group Inc. operates the world’s largest electronic interdealer quotation system for US broker dealers and offers multiple media channels to increase the visibility of OTC-listed companies. Independent studies show that trading on the OTCQB by an international company offers a positive effect on the liquidity of its shares.
Trading on the OTCQB market will have no impact on the IQ-AI ordinary shares admitted to listing on the London Stock Exchange’s Main Market under the symbol “IQAI”, and no new ordinary shares have been admitted as part of the OTCQB listing. The Company will continue to rely on the announcements and disclosures it makes to the London Stock Exchange and has no Sarbanes-Oxley or SEC reporting requirements.
IQ-AI CEO, Trevor Brown, commented:
“The United States is home to some of the world’s most influential medical technology investors. By joining OTCQB, we now have an effective platform from which to reach a significantly larger investor audience and we look forward to providing investors in both the UK and the United States with regular progress updates at this exciting and pivotal time for the Company.”
Jonathan Dickson, VP of International Corporate Services at OTC Markets, said:
“Congratulations to IQ-AI Ltd on joining the OTCQB Venture Market. We are pleased to support innovative and entrepreneurial international companies seeking to strengthen transparency and to provide better access to disclosure and trading for investors in the United States. Cross-trading on OTCQB in the U.S will enable IQ-AI, which is listed on the London Stock Exchange’s Main Market, to diversify its investor base and to expand its global engagement even further.”
The Company would like to thank Nikolaos Galanopoulos of Galanopoulos & Company, the corporate securities law firm that acted as Sponsor for the Company’s application to commence cross-trading on the OTCQB.
The Directors of the Company accept responsibility for the contents of this announcement.
Trevor Brown/Dr Qu Li/Vinod Kaushal
0207 469 0930
Peterhouse Capital Limited
Lucy Williams/Heena Karani
0207 220 9797